Organisation paid for research Program year 2025 Source: CMS Open Payments

Amicis Research Center Valencia

Neither a doctor nor a teaching hospital

Research payments

$87,239

72 payments

Through program year 2025, Amicis Research Center Valencia is reported as receiving $87,239 in research payments, across 72 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2025	Research	$51,162	57
2024	Research	$36,077	15

Breakdown

Who paid Research payments · program years 2024–2025

Incyte Corporation $69,499 71 payments
Vertex Pharmaceuticals Incorporated $17,741 1 payment

Studies the money was for Research payments · program years 2024–2025

A study to evaluate the safety and tolerability of maximal use Ruxolitinib Cream $36,077 15 payments
A Maximal Use Trial of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa $22,466 6 payments
An Open-Label, Multiple-Ascending Dose Study to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Different Dose Levels of Povetacicept in Subjects With Autoantibody-Associated Glomerular Diseases (RUBY-3) $17,741 1 payment
A study to evaluate the safety and tolerability of maximal use Ruxolitinib Cream $10,955 50 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.